Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 0Receivables
VS
Market
Sector
Industry
History
$ 9.84Close
$ 2.51 - $ 10.09 52-Week Range
Ticker Information
Ticker
FDMTCompany Name
4D MOLECULAR THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQ4D MOLECULAR THERAPEUTICS INC - Receivables Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
FDMT - Receivables Historical data
| Date | Receivables |
|---|---|
| 6/30/2025 | $ 0 |
| 3/31/2025 | $ 0 |
| 12/31/2024 | $ 0 |
| 9/30/2024 | $ 0 |
| 6/30/2024 | $ 0 |
| 3/31/2024 | $ 0 |
| 12/31/2023 | $ 0 |
| 9/30/2023 | $ 0 |
| 6/30/2023 | $ 0 |
| 3/31/2023 | $ 0 |
Key Performance Insights, Last 5 Years
- 4D MOLECULAR THERAPEUTICS INC's latest trailing twelve months (TTM) Receivables stands at $ 896K.
- Over the past 5 years, 4D MOLECULAR THERAPEUTICS INC's average Receivables has been $ 270.15K.
- The median Receivables for 4D MOLECULAR THERAPEUTICS INC during this period was $ 0
- 4D MOLECULAR THERAPEUTICS INC reached its highest Receivables over the past 5 years at $ 1.49M.
- The lowest Receivables recorded by 4D MOLECULAR THERAPEUTICS INC in the same timeframe $ 0
4D MOLECULAR THERAPEUTICS INC's Receivables vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Receivables Benchmarks
Similar metrics to Receivables:
- Investments - [Balance Sheet] A component of [Assets] representing the total amount of marketable and non-marketable securities, loans receivable and other invested assets.
- Payables - [Balance Sheet] A component of [Liabilities] representing a company’s received goods or services from its suppliers on credit.
- Inventory - [Balance Sheet] Inventory is a component of [Assets] that represents the expected market value of inventories in all stages of completion.
- Current Assets - [Balance Sheet] The current (short-term) portion of [Assets] that are usually convertible to cash within a year; reported if the company operates a classified balance sheet that segments current and non-current assets.
- Total Assets - [Balance Sheet] An asset represents anything that has current and/or future economic value to a company. This includes Cash [CashnEq], [Investments], [Intangibles], [Receivables] and more.
Definition of Receivables
[Balance Sheet] Receivables are a component of [Assets] representing short term debts owed to the company.FDMT - Receivables, Last 5 years
$ 0
Minimum
Mar 31, 2022
$ 1.49M
Maximum
Dec 31, 2020
$ 270.15K
Average
$ 0
Median
Receivables Benchmark AnalysisMarket
The chart above depicts the distribution of Receivables for companies in the Total Stock Market. The average Receivables of the companies is $ 28.79M with a standard deviation of $ 46.25M.
The following table provides additional summary stats:
Receivables in the Market:
| filtered constituents | 3.12K |
|---|---|
| min | $ 0 |
| max | $ 189.89M |
| average | $ 28.79M |
| median | $ 3M |
| std | $ 46.25M |